EUVIMEDEUVIMED entdecken
Crossref

Infiltration of CD4, CD8, CD56, and Fox-P3-positive lymphocytes in breast carcinoma tissue after neoadjuvant chemotherapy with or without trastuzumab1

Naoko Itoi, Tomoko Umeda, Mitsuaki Ishida, Satoshi Murata, Tsuyoshi Mori, Yuki Kawai, Kaori Tomida, Tomoharu Shimizu, Ryoji Kushima, Masaji Tani

Breast Disease · 26.06.2019 · 38 (2) · 57-65

DOI: 10.3233/bd-180350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Disease, erschienen am 26.06.2019. Verfasst von Naoko Itoi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Shiga University of Medical Science, Tsukinowa-cho, Seta, Otsu, Shiga, 520-2192, Japan. Hauptthemen laut MEDLINE: Adaptive Immunity, Immunity, Cellular, Neoadjuvant Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Trastuzumab (Tz) is assumed to prime antibody-dependent cellular cytotoxicity (ADCC); however, it remains unclear whether Tz therapy can clinically induce adaptive cellular immunity. OBJECTIVE: Adaptive Cellular Immune Effect of Tz Therapy. METHODS: This study included 29 surgical invasive breast carcinomas administered neoadjuvant chemotherapy with Tz (15 cases) or without Tz (14 cases). The numbers of immunoreactive cells (CD4, CD8, CD56, and Fox-P3) in three different compartments (intratumoral, adjacent stromal, and distant stromal) were determined. RESULTS: The average number of adjacent stromal CD4-positive, CD8-positive, and Fox-P3-positive cells in the Tz+ group was significantly greater than that in the Tz− group (p = 0.036, 0.0049, and 0.043, respectively). However, the number of Fox-P3-positive cells was much less than that of CD4-positive cells. Moreover, distant stromal CD4-positive and CD8-positive cells in the Tz+ group was also significantly greater than that of the Tz− group (p = 0.029 and 0.032, respectively). Only a small number of CD56-positive natural killer cells, playing a main role in ADCC, accumulated at the tumor site after Tz therapy. CONCLUSIONS: The results suggest that Tz therapy induces adaptive cellular immunity, including infiltration of both CD4-positive helper T cells and CD8-positive cytotoxic T cells into the breast carcinoma lesion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adaptive ImmunityImmunity, CellularNeoadjuvant TherapyAdultAgedAntineoplastic Agents, ImmunologicalAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsCD4-Positive T-LymphocytesCD56 AntigenCD8-Positive T-LymphocytesCell MovementFemaleHepatocyte Nuclear Factor 3-gammaHumansMiddle AgedTrastuzumab

Stichwörter der Autor:innen

Breast carcinomaHER2immunohistochemistrytrastuzumabtumor-infiltrating lymphocyte

Substanzen

Antineoplastic Agents, ImmunologicalCD56 AntigenFOXA3 protein, humanNCAM1 protein, humanHepatocyte Nuclear Factor 3-gammaTrastuzumab

Autor:innen und Institutionen

  • Department of Surgery, Shiga University of Medical Science, Tsukinowa-cho, Seta, Otsu, Shiga, 520-2192, Japan.
  • Consortium for Community Medicine, Shiga University of Medical Science, Tsukinowa-cho, Seta, Otsu, Shiga, 520-2192, Japan.
  • Department of Breast surgery, Japan Community Healthcare Organization (JCHO) Shiga Hospital, 16-1 Fujimidai, Shiga, 520-0846, Japan.
  • Department of Pathology and Laboratory Medicine, Kansai Medical University, 2-3-1, Shin-machi, Hirakata, Osaka, 573-1191, Japan.
  • Department of Clinical Laboratory Medicine and Division of Diagnostic Pathology, Shiga University of Medical Science, Tsukinowa-cho, Seta, Otsu, Shiga, 520-2192, Japan.

Zitieren

APA

Itoi, N., Umeda, T., Ishida, M., Murata, S., Mori, T., Kawai, Y., Tomida, K., Shimizu, T., Kushima, R., & Tani, M. (2019). Infiltration of CD4, CD8, CD56, and Fox-P3-positive lymphocytes in breast carcinoma tissue after neoadjuvant chemotherapy with or without trastuzumab1. Breast Disease, 38(2), 57-65. https://doi.org/10.3233/bd-180350

Vancouver

Itoi N, Umeda T, Ishida M, Murata S, Mori T, Kawai Y, et al. Infiltration of CD4, CD8, CD56, and Fox-P3-positive lymphocytes in breast carcinoma tissue after neoadjuvant chemotherapy with or without trastuzumab1. Breast Disease. 2019;38(2):57-65. doi:10.3233/bd-180350

BibTeX
@article{Itoi2019,
  author = {Itoi, Naoko and Umeda, Tomoko and Ishida, Mitsuaki and Murata, Satoshi and Mori, Tsuyoshi and Kawai, Yuki and Tomida, Kaori and Shimizu, Tomoharu and Kushima, Ryoji and Tani, Masaji},
  title = {Infiltration of CD4, CD8, CD56, and Fox-P3-positive lymphocytes in breast carcinoma tissue after neoadjuvant chemotherapy with or without trastuzumab1},
  journal = {Breast Disease},
  year = {2019},
  volume = {38},
  number = {2},
  pages = {57--65},
  doi = {10.3233/bd-180350}
}
Kostenlos starten →